Annual Drug Patent Expirations for DEFINITY+RT
Definity Rt is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has forty-three patent family members in fourteen countries.
The generic ingredient in DEFINITY RT is perflutren. One supplier is listed for this compound. Additional details are available on the perflutren profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
